Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: A monocenter observational study with clinical and JC virus load monitoring

References

• Andrei G, Snoeck R, Vandeputte M, De Clercq E (1997). Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chem other 41: 587–593.
   PubMed Web of Science ®Google Scholar
• Berenguer J, Miralles P, Arrizabalaga J, Ribera E, Dronda F, Baraia J, Domingo P, Marquez M, Rodriguez-Arrondo FJ, Laguna F, Rubio R, Lopez-Aldeguer J, De Miguel V, and the Gesida 11/99 Study Group (2001). Clinical Course and Prognostic Factors of AIDS-Associated Pro-gressive Multifocal Leukoencephalopathy (PML) in Pa-tients Treated with HAART (GESIDA 11/99). The 8th Conference on Retroviruses and Opportunistic Infec-tions, Abstract 10. February 4–8, Chicago, IL, USA.
   Google Scholar
• Blick G, Whiteside M, Griegor P, Hopkins U, Garton T, LaGravinese L (1998). Successful resolution of progres-sive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside. Clin Infect Dis 26: 191–192.
   Google Scholar
• Brambilla AM, Castagna A, Novati R, Cinque P, Terreni MR, Moioli MC, Lazzarin A (1999). Remission of AIDS-associated progressive multifocal leukoencephalo-pathy after cidofovir therapy. J Neurol 246: 723–725.
   PubMed Web of Science ®Google Scholar
• Brott TG, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M (1989). Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20: 864–870.
   Google Scholar
• Cinque P, Casari S, Bertelli D (1998). Progressive multifocal leukoencephalopathy, HIV, and highly active antiretro-viral therapy. N Engl J Med 339: 848–849.
   Google Scholar
• Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART im-proves prognosis in HIV-associated progressive multifo-cal leukoencephalopathy. Neurology 52: 623–625.
   PubMed Web of Science ®Google Scholar
• De Luca A, Fantoni M, Tartaglione T, Antinori A (1999). Response to cidofovir after failure of antiretro-viral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 52: 891–892.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Paglia MG, Govoni A, Murri R, Testa L, Monforte AD, Antinori A (2000a). Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoen-cephalopathy. AIDS 14: 117–121.
   Google Scholar
• De Luca A, Giancola ML, Ammassari A, Grisetti S, Paglia MG, Gentile M, Cingolani A, Murri R, Liuzzi G, Monforte AD, Antinori A (2000b). The effect of potent antiretro-viral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy. J Infect Dis 182: 1077–1083.
   PubMed Web of Science ®Google Scholar
• Dworkin MS, Wan PC, Hanson DL, Jones JL (1999). Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. I Infect Dis 180: 621–625.
   PubMed Web of Science ®Google Scholar
• Gasnault J, Taoufik Y, Goujard C, Kousignian P, Abbed K, Boue F, Dussaix E, Delfraissy JF (1999). Pro-longed survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretrovi-ral therapy. J Neurovirol 5: 421–429.
   PubMed Web of Science ®Google Scholar
• Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly active antiretroviral therapy and progressive multifo-cal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95–99.
   PubMed Web of Science ®Google Scholar
• Kurtzke JF (1983). Rating neurologic impairment in multi-ple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444–1452.
   PubMed Web of Science ®Google Scholar
• Labetoulle M, Goujard C, Frau E, Offret H, Delfraissy JF, Gasnault J (2000). Cidofovir ocular toxicity is related to previous ocular history. AIDS 14: 622–623.
   Google Scholar
• Marra CM, Rajicic N, Barker DE, Cohen B, Clifford D, and the ACTG 363 Team (2001). Prospective Pilot Study of Cidofovir for HIV-Associated Progressive Multifocal Leukoencephalopathy (PML). The 8th Conference on Retroviruses and Opportunistic Infections, Abstract 596. February 4–8, Chicago, IL, USA.
   Google Scholar
• Meylan PR, Vuadens P, Maeder P, Sahli R, Tagan MC (1999). Monitoring the response of AIDS-related progressive multifocal leukoencephalopathy to HAART and cido-fovir by PCR for JC virus DNA in the CSF. Eur Neurol 41: 172–174.
   PubMed Web of Science ®Google Scholar
• Miralles P, Berenguer J, Garcia de Viedma D, Padilla B, Cosin J, Lopez-Bernaldo de Quiros JC, Munoz L, Moreno S, Bouza E (1998). Treatment of AIDS-associated pro-gressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12: 2467–2472.
   PubMed Web of Science ®Google Scholar
• Sadler M, Chinn R, Healy J, Fisher M, Nelson MR, Gazzard BG (1998). New treatments for progressive multifocal leukoencephalopathy in HIV-1-infected patients. AIDS 12: 533–535.
   PubMedGoogle Scholar
• Taoufik Y, Delfraissy JF, Gasnault J (2000). Highly ac-tive antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy di-agnosis. AIDS 14: 758–759.
   PubMed Web of Science ®Google Scholar
• Taoufik Y, Gasnault J, Karaterki A, Pierre Ferey M, Marchadier E, Goujard C, Lannuzel A, Delfraissy JF, Dussaix E (1998). Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive mul-tifocal leukoencephalopathy. I Infect Dis 178: 1816–1820.
   PubMed Web of Science ®Google Scholar
• Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boue F, Billaud E, Costagliola D, and the Clinical Epi-demiology Group from the French Hospital Database on HIV (1999). Survival improvement of AIDS-related progressive multifoc al leukoencephalopathy in the era of protease inhibitors. AIDS 13: 1881–1887.
   PubMed Web of Science ®Google Scholar